{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:17:33Z","timestamp":1791001053782,"version":"4.1.0"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,6,22]]},"DOI":"10.18632\/aging.103113","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T18:47:11Z","timestamp":1592851631000},"page":"11349-11363","source":"Crossref","is-referenced-by-count":9,"title":["Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1"],"prefix":"10.18632","volume":"12","author":[{"given":"Shanshan","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"},{"name":"Institute of Zoology, Chinese Academy of Sciences, Chaoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"},{"name":"Department of Neurology, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Piao","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwei Lucy","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"},{"name":"Clinical College, Jilin University, Changchun, China"},{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"},{"name":"Department of Orthopaedic Surgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihang","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"},{"name":"Department of Orthopaedic Surgery, Xijing Hospital, The Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Ren","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4048\/jbc.2019.22.e23","article-title":"Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer.","volume":"2","author":"Jia","year":"2019","journal-title":"J Breast Cancer"},{"key":"2","doi-asserted-by":"publisher","first-page":"e15289","DOI":"10.1097\/MD.0000000000015289","article-title":"Combined endoscopic submucosal dissection and transanal minimally invasive surgery for the management of lower rectal adenoma extending above the dentate line: A case report.","volume":"9","author":"Natsugoe","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ejmech.2018.11.010","article-title":"Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase.","volume":"16","author":"Malachowski","year":"2019","journal-title":"Eur J Med Chem"},{"key":"4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.117.030972","article-title":"Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice In Vivo.","volume":"13","author":"Zou","year":"2017","journal-title":"Circulation"},{"key":"5","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jaci.2015.09.055","article-title":"The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases.","volume":"13","author":"Lowes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bmcl.2018.01.010","article-title":"Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.","volume":"2","author":"Covello","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.taap.2017.03.012","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.","volume":"32","author":"Tomlinson","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"key":"8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.4049\/jimmunol.1301828","article-title":"IDO-independent suppression of T cell effector function by IFN-\u03b3-licensed human mesenchymal stromal cells.","volume":"19","author":"Galipeau","year":"2014","journal-title":"J Immunol"},{"key":"9","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1182\/blood-2010-06-288498","article-title":"Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.","volume":"11","author":"Andersen","year":"2011","journal-title":"Blood"},{"key":"10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jamcollsurg.2008.12.018","article-title":"Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.","volume":"20","author":"Brody","year":"2009","journal-title":"J Am Coll Surg"},{"key":"11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jamcollsurg.2007.12.014","article-title":"Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.","volume":"20","author":"Brody","year":"2008","journal-title":"J Am Coll Surg"},{"key":"12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2005-08-3507","article-title":"CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition.","volume":"10","author":"Schultze","year":"2006","journal-title":"Blood"},{"key":"13","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1182\/blood-2004-06-2103","article-title":"Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?","volume":"10","author":"Opelz","year":"2005","journal-title":"Blood"},{"key":"14","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 Inhibitors: From Bench to Bedside.","volume":"7","author":"Muller","year":"2017","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1038\/sj.onc.1210939","article-title":"A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.","volume":"2","author":"Muller","year":"2008","journal-title":"Oncogene"},{"key":"16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-007-9635-y","article-title":"Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells.","volume":"30","author":"Ghahary","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10616-007-9081-4","article-title":"etc. Transcriptional regulation of indoleamine 2,3-dioxygenase (IDO) by tryptophan and its analogue.","volume":"5","author":"Minatogawa","year":"2007","journal-title":"Cytotechnology"},{"key":"18","doi-asserted-by":"publisher","first-page":"8136","DOI":"10.18632\/oncotarget.2357","article-title":"A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors.","volume":"5","author":"Antonia","year":"2014","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-1-60761-869-0_19","article-title":"Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.","volume":"67","author":"Grohmann","year":"2011","journal-title":"Methods Mol Biol"},{"key":"20","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1007\/s10620-017-4651-6","article-title":"The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.","volume":"6","author":"Seishima","year":"2017","journal-title":"Dig Dis Sci"},{"key":"21","doi-asserted-by":"publisher","first-page":"37762","DOI":"10.18632\/oncotarget.9326","article-title":"The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.","volume":"7","author":"Hodge","year":"2016","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ygyno.2017.07.005","article-title":"A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer.","volume":"14","author":"Maleski","year":"2017","journal-title":"Gynecol Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/acsmedchemlett.6b00391","article-title":"INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology.","volume":"8","author":"Leffet","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"24","doi-asserted-by":"publisher","first-page":"JCO2018789602","DOI":"10.1200\/JCO.2018.78.9602","article-title":"Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I\/II Trial (ECHO-202\/KEYNOTE-037).","volume":"3","author":"Gajewski","year":"2018","journal-title":"J Clin Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1158\/1078-0432.CCR-16-2272","article-title":"First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies.","volume":"2","author":"Gajewski","year":"2017","journal-title":"Clin Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40425-019-0562-8","article-title":"Phase 1\/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma.","volume":"7","author":"Weber","year":"2019","journal-title":"J Immunother Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40425-018-0351-9","article-title":"Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors.","volume":"6","author":"Liang","year":"2018","journal-title":"J Immunother Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"e0216678","DOI":"10.1371\/journal.pone.0216678","article-title":"Computational study on new natural compound agonists of stimulator of interferon genes (STING).","volume":"1","author":"Jin","year":"2019","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/ijms17030340","article-title":"Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.","volume":"1","author":"Sun","year":"2016","journal-title":"Int J Mol Sci"},{"key":"30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bmcl.2013.11.079","article-title":"Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.","volume":"2","author":"Zhu","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-5971-8","volume-title":"Integrative Approach by PPPM. Mozaffari MS (editor).","author":"New Strategies to Advance Pre\/Diabetes Care","year":"2013"},{"key":"32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ics.2007.07.051","article-title":"Introduction of indoieamine 2,3-dioxygenase in small intestine of mouse infected with parasitic helminth, Hymenolepis nana.","volume":"130","author":"Minatogawa","year":"2007","journal-title":"Int Congr Ser"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Abstracts from 8th International ISSX Meeting. Drug Metab Rev. 2010; 39:1-388. https:\/\/doi.org\/10.1080\/03602530701532865.","DOI":"10.1080\/03602530701532865"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Li, Ba, Jin. Effect of Fe Doping on the Crystal Structures and Photoluminescence of ZnO Nanorods. Key Eng Mater. 2014; 636:105-09. https:\/\/doi.org\/10.4028\/www.scientific.net\/KEM.636.105.","DOI":"10.4028\/www.scientific.net\/KEM.636.105"},{"key":"35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1017\/S0029665112000560","article-title":"Towards amino acid recommendations for specific physiological and patho-physiological states in pigs.","volume":"7","author":"Quesnel","year":"2012","journal-title":"Proc Nutr Soc"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:28:21Z","timestamp":1599078501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,30]]}},"alternative-id":["103113","32568737"],"URL":"https:\/\/doi.org\/10.18632\/aging.103113","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]}}}